Membrane chromatography built to scale.

Drive operational efficiency with easy-to-use technology designed for rapid results

Designed for Today’s Biologics 

Purilogics is improving the purification process with membrane chromatography to meet the demands of complex biologics. Purexa® membranes overcome the limitations of traditional purification technology with rapid changeover, high recovery, and reliable performance. 

Fast flow rates, easy setup, and no incubation periods reduce production stress. Durable and efficient, our membranes cycle quickly without degradation or fouling — delivering consistent results at any scale.

 

Life Science evolves.
Donaldson solves.

Purilogics is a part of Donaldson Company, Inc. and its focus on Life Sciences and Bioprocessing. Learn more 🡒

 
 

Scientific Validation & Case Studies of Purexa™

Featured
Addressing the Plasmid DNA Manufacturing Bottleneck
Addressing the Plasmid DNA Manufacturing Bottleneck

Over the past few years, we have seen a steady increase in the demand for plasmid DNA, as the gene and cell therapy industries have experienced rapid growth…

Read More →
How Does Flow Rate Affect the Binding Capacity of Purexa™ Membranes?
How Does Flow Rate Affect the Binding Capacity of Purexa™ Membranes?

At Purilogics, we take pride in designing and developing membrane chromatography technologies for biologics purification. Our mission is to provide rapid and effective purification solutions to help the biopharmaceutical industry simplify biologics purification.

Read More →
Purexa™ PrA mini - Fast Antibody Purification within 1 Minute
Purexa™ PrA mini - Fast Antibody Purification within 1 Minute

Purexa™ PrA mini is designed for rapid processing of small quantity of antibodies, especially at low titers. During elution, the first 0.5 mL was discarded. As is shown in the fitures, a majority of the antibody was eluted in the second 0.5 mL elution fraction, which had a concentration of 3.3 mg/mL and was corresponding to a recovery of 78%.

Read More →